# Evaluation of Block Duration in Type 2 Diabetes Patients

> **NCT01704612** · PHASE4 · COMPLETED · sponsor: **Pierre and Marie Curie University** · enrollment: 70 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** ropivacaine

## Key facts

- **NCT ID:** NCT01704612
- **Lead sponsor:** Pierre and Marie Curie University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2012-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704612, "Evaluation of Block Duration in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01704612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*